dalteparin has been researched along with HbS Disease in 8 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sickle cell disease is one of the most common and severe genetic disorders in the world." | 2.52 | Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease. ( Fedorowicz, Z; van Zuuren, EJ, 2015) |
| "Pain is the most prominent symptom of vasoocclusion, and hypercoagulability is a well-established pathogenic phenomenon in people with sickle cell disease." | 2.50 | Low-molecular-weight heparins for managing vasoocclusive crises in people with sickle cell disease: a summary of a cochrane systematic review. ( Fedorowicz, Z; van Zuuren, EJ, 2014) |
| "Sickle cell disease is one of the most common and severe genetic disorders in the world." | 2.49 | Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease. ( Fedorowicz, Z; van Zuuren, EJ, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Sakon, C | 1 |
| Nikirk, M | 1 |
| O'Brien, ARW | 1 |
| Vianello, A | 1 |
| Vencato, E | 1 |
| Cantini, M | 1 |
| Zanconato, G | 1 |
| Manfrin, E | 1 |
| Zamo, A | 1 |
| Zorzi, F | 1 |
| Mazzi, F | 1 |
| Martinelli, N | 1 |
| Cavaliere, E | 1 |
| Monari, F | 1 |
| Venturelli, D | 1 |
| Ferrara, F | 1 |
| Olivieri, O | 1 |
| De Franceschi, L | 1 |
| Alli, NA | 1 |
| Wainwright, RD | 1 |
| Mackinnon, D | 1 |
| Poyiadjis, S | 1 |
| Naidu, G | 1 |
| van Zuuren, EJ | 3 |
| Fedorowicz, Z | 3 |
| Telen, MJ | 1 |
| Batchvarova, M | 1 |
| Shan, S | 1 |
| Bovee-Geurts, PH | 1 |
| Zennadi, R | 1 |
| Leitgeb, A | 1 |
| Brock, R | 1 |
| Lindgren, M | 1 |
| Qari, MH | 1 |
| Aljaouni, SK | 1 |
| Alardawi, MS | 1 |
| Fatani, H | 1 |
| Alsayes, FM | 1 |
| Zografos, P | 1 |
| Alsaigh, M | 1 |
| Alalfi, A | 1 |
| Alamin, M | 1 |
| Gadi, A | 1 |
| Mousa, SA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Randomized, Double-blind, Placebo Controlled, Multi-national Study of Therapeutic Anticoagulation Strategy for Acute Chest Syndrome in Adults[NCT02580773] | Phase 3 | 200 participants (Anticipated) | Interventional | 2016-12-16 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for dalteparin and HbS Disease
| Article | Year |
|---|---|
Skull bone infarctive crisis and deep vein thrombosis in homozygous sickle cell disease- case report and review of the literature.
Topics: Anemia, Sickle Cell; Anticoagulants; Catheterization; Child; Diagnosis, Differential; Edema; Enoxapa | 2007 |
Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.
Topics: Anemia, Sickle Cell; Anticoagulants; Dalteparin; Heparin, Low-Molecular-Weight; Humans; Pain Measure | 2015 |
Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.
Topics: Anemia, Sickle Cell; Anticoagulants; Heparin, Low-Molecular-Weight; Humans; Peripheral Vascular Dise | 2013 |
Low-molecular-weight heparins for managing vasoocclusive crises in people with sickle cell disease: a summary of a cochrane systematic review.
Topics: Anemia, Sickle Cell; Female; Fibrinolytic Agents; Hemolysis; Heparin, Low-Molecular-Weight; Humans; | 2014 |
1 trial available for dalteparin and HbS Disease
| Article | Year |
|---|---|
Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antisickling Agents; Double-Blind Method; Female; Fibrinolyt | 2007 |
3 other studies available for dalteparin and HbS Disease
| Article | Year |
|---|---|
Enoxaparin adherence for venous thromboembolism prophylaxis in hospitalized patients with sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Anticoagulants; Enoxaparin; Humans; Retrospective Studies; Venous Thromb | 2023 |
Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis.
Topics: Abortion, Spontaneous; Adult; Anemia, Sickle Cell; Anticoagulants; Birth Weight; Cross-Sectional Stu | 2018 |
Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell-induced vaso-occlusion.
Topics: Anemia, Sickle Cell; Animals; Arterial Occlusive Diseases; Cell Adhesion; Cells, Cultured; Endotheli | 2016 |